| Literature DB >> 24455748 |
Xuejie Yi1, Shicheng Cao2, Bo Chang3, Dalin Zhao3, Haining Gao3, Yihan Wan3, Jiaojiao Shi3, Wei Wei3, Yifu Guan4.
Abstract
AIM: To investigate the effects of acute and chronic exercise on glucose and lipid metabolism in liver of rats with type 2 diabetes caused by a high fat diet and low dose streptozotocin (STZ).Entities:
Mesh:
Substances:
Year: 2013 PMID: 24455748 PMCID: PMC3877642 DOI: 10.1155/2013/946432
Source DB: PubMed Journal: J Diabetes Res Impact factor: 4.011
Body weight and biochemical parameters of different groups.
| CON | DC | DCE | DAE | |
|---|---|---|---|---|
| Weight (g) | 520.7 ± 12.00 | 502.8 ± 10.51 | 527.3 ± 10.77 | 507.3 ± 13.16 |
| Epididymal fat (g) | 8.83 ± 0.43 | 7.86 ± 0.34 | 8.61 ± 0.44 | 8.12 ± 0.45 |
| Insulin (pmol/L) | 66.14 ± 2.80 | 76.29 ± 4.17 | 70.86 ± 3.61 | 68.70 ± 3.34 |
| FBG (mmol/L) | 5.35 ± 0.23 | 13.18 ± 0.52** | 11.57 ± 0.42# | 11.51 ± 0.41# |
| Kitt (%/min) | 3.19 ± 0.19 | 1.95 ± 0.30** | 2.87 ± 0.22# | 2.61 ± 0.15# |
| TG (mmol/L) | 1.68 ± 0.09 | 2.06 ± 0.11** | 1.79 ± 0.10# | 2.12 ± 0.07$ |
| TC (mmol/L) | 4.15 ± 0.26 | 5.78 ± 0.39** | 4.69 ± 0.21# | 5.67 ± 0.35$ |
| FFA (mmol/L) | 0.39 ± 0.01 | 0.63 ± 0.05** | 0.49 ± 0.04# | 0.60 ± 0.04 |
| HDL-C (mmol/L) | 1.730 ± 0.33 | 1.029 ± 0.10** | 1.358 ± 0.16# | 0.94 ± 0.29 |
| LDL-C (mmol/L) | 0.27 ± 0.12 | 1.21 ± 0.24** | 0.51 ± 0.19## | 1.25 ± 0.35$$ |
| Leptin (ng/mL) | 3.25 ± 0.38 | 5.39 ± 0.64** | 4.41 ± 0.61# | 5.28 ± 0.49 |
Results were expressed as mean ± standard error (n = 7-8). Differences between groups were compared by one-way analysis of variance (ANOVA).
Note: in comparison with the control group: **P < 0.01, *P < 0.05; in comparison with the diabetes group: ## P < 0.01, # P < 0.05; in comparison with the chronic exercise group: $$ P < 0.01, $ P < 0.05.
The effects of exercise on liver glycolipid storage in type 2 diabetes rats.
| CON | DC | DCE | DAE | |
|---|---|---|---|---|
| Hepatic G (mg/g) | 42.31 ± 5.80 | 19.86 ± 2.32* | 38.45 ± 6.34# | 17.64 ± 4.67 |
| Hepatic TG ( | 35.2 ± 20.1 | 144.1 ± 50.4** | 51.0 ± 15.3## | 138.4 ± 33.4 |
| Hepatic FAA ( | 103.4 ± 35.8 | 179.4 ± 36.2** | 116.9 ± 27.5# | 163.9 ± 43.9 |
Results were expressed as mean ± standard error (n = 7-8). Differences between the groups were compared by one-way analysis of variance (ANOVA).
Note: compared with normal control group: **P < 0.01, *P < 0.05; compared with the diabetes control group: ## P < 0.01, # P < 0.05.
Figure 2Western blotting images of protein expression and protein phosphorylation related to the leptin-AMPK-ACC signaling pathway of different groups of type 2 diabetes rats. (a) Leptin and its receptor. (b) AMPKα1/2 and p-AMPKα1/2. (c) AMPKα1 and p-AMPKα1. (d) AMPKα2 and p-AMPKα2. (e) ACC and p-ACC. (f) GADPH as an internal standard.
Figure 1Histograph showing the effects of exercise on the leptin-AMPK-ACC pathway in type 2 diabetes rats. The relative levels of protein phosphorylation and protein expression related to the leptin-AMPK-ACC signaling pathway on different groups were shown. (a) Leptin and its receptor. (b) AMPK1/2 and p-AMPK1/2 (Thr172). (c) AMPKα1 and p-AMPKα1 (Thr172). (d) AMPKα2 and p-AMPKα2 (Thr172). (e) ACC and p-ACC (Ser79). Note: in comparison with the control group: **P < 0.01, *P < 0.05; in comparison with the diabetes group: ## P < 0.01, # P < 0.05 (n = 8).